Ignite Creation Date:
2025-12-25 @ 4:42 AM
Ignite Modification Date:
2025-12-26 @ 3:44 AM
Study NCT ID:
NCT04817618
Status:
RECRUITING
Last Update Posted:
2025-03-04
First Post:
2021-03-23
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07-28
Start Date Type:
ACTUAL
Primary Completion Date:
2026-03-27
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-07-04
Completion Date Type:
ESTIMATED
First Submit Date:
2021-03-23
First Submit QC Date:
None
Study First Post Date:
2021-03-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-01
Last Update Post Date:
2025-03-04
Last Update Post Date Type:
ACTUAL